EXAMINE THIS REPORT ON ANTIRETROVIRAL THERAPY

Select other brokers are proposed as alternative agents determined by administration difficulties and/or adverse result profile.  Zidovudine combined with lamivudine is the alternative NRTI backbone but is affiliated with much more hematologic toxicity. Lopinavir/ritonavir is an alternate PI agent with established protection but exhibits greater g